Looking to sell Viz.ai stock or options?
Viz.ai develops an intelligent care coordination platform aimed at transforming global healthcare delivery. The platform utilizes advanced deep learning to promptly relay critical information about stroke patients directly to specialists for timely intervention. This technology enables healthcare providers to expedite treatment times and enhance access to care.
Camford Capital, Susa Ventures, Greenoaks Capital Partners, AME Cloud Ventures, Seedcamp, Kevin Ding, Threshold Ventures, Jukka Jokinen, Halle Tecco, Scale Venture Partners, GV, CRV, Pear (California), Insight Partners (New York), DHVC, Geodesic Capital, Tiger Global Management, J Mocco, Canadian Imperial Bank of Commerce, Kleiner Perkins, Hakluyt Capital, Innovation Endeavors, Sozo Ventures, Kivu Ventures.
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read moreViz.ai Integrates Avicenna.AI's Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One Platform
Read moreSAN FRANCISCO - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced Chris Mansi, MD, CEO and Co-founder, will present at the Morgan Stanley 22nd...
Read moreCollaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary strokeSAN FRANCISCO--(BUSINESS
Read moreNew AI algorithm enables precise and reliable quantification of intracerebral hemorrhage to make accurate and timely treatment decisionsSAN
Read moreThe AI-powered diagnostic platform can diagnose the presence of aneurysms by analysing computed tomography (CT) scans.
Read moreThe startup has 12 FDA-approved algorithms, agreements with more than 1,500 U.S. hospitals, and plans to work with drug companies to reduce healthcare roadblocks.
Read moreSAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of VizTM Vascular Suite, AI-powered software enabling vascular care teams to automatically detect and triage…
Read moreSAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has received two additional Comparably Best Place to Work Awards for Best Company Culture and Best Company for Diversity in 2022. Earli…
Read moreSAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a partnership with Cercare Medical, which delivers next-level medical imaging with CT and MRI. The partnership will inc…
Read more